Is baclofen appropriate for treating jaw clenching (bruxism), and what dosing and monitoring are recommended?

Baclofen is NOT appropriate as a first-line treatment for jaw clenching (bruxism)

Baclofen is FDA-approved only for spasticity from multiple sclerosis and spinal cord conditions—NOT for bruxism or temporomandibular disorders 1. The available evidence does not support its use for jaw clenching, and safer, more effective alternatives exist.

Why Baclofen Should Not Be Used for Jaw Clenching

Lack of Evidence for Bruxism

• No guidelines or research evidence supports baclofen for bruxism treatment 2, 3
• The 2023 BMJ guideline on chronic TMD pain management does not mention baclofen as a treatment option 4
• Baclofen's mechanism as a GABA-B agonist targets spasticity from central nervous system injury, not the repetitive jaw-muscle activity characteristic of bruxism 5, 6

Significant Safety Concerns

The risk profile makes baclofen particularly problematic for a condition like bruxism that has safer alternatives:

• Common adverse effects: Dizziness, somnolence, mental clouding, and gastrointestinal symptoms 6
• Severe withdrawal risk: Abrupt discontinuation can cause visual/auditory hallucinations, anxiety, delirium, fever, tremors, tachycardia, and seizures 7
• Increased fall risk: Particularly concerning in older adults 6
• CNS depression: Can worsen when combined with other sedating medications 7

FDA-Approved Indications Are Specific

Baclofen is indicated exclusively for:

• Spasticity from multiple sclerosis
• Spinal cord injuries and diseases
• Explicitly NOT indicated for skeletal muscle spasm from rheumatic disorders 1

Bruxism involves repetitive muscle activity, not velocity-dependent spasticity—a fundamentally different pathophysiology.

What SHOULD Be Used for Jaw Clenching

First-Line Conservative Approaches 4

1. Education and reassurance about the condition
2. Behavioral modifications: Avoid wide mouth opening, aggravating activities, stress management
3. Physical interventions: Jaw exercises, massage, heat/cold application
4. Sleep hygiene and relaxation techniques 2

Evidence-Based Pharmacological Options (When Needed)

• NSAIDs for pain relief 4
• Occlusal splints to prevent dental damage (though effects on EMG activity are transient) 2
• Botulinum toxin A for severe cases with functional impairment (speaking, chewing, swallowing difficulties)—provides relief for 1-5 months 2, 3
• Clonazepam (acute use only) has been reported to improve sleep bruxism in patients with psychiatric comorbidities, though double-blind trials are lacking 2

Medications That May Help (Limited Evidence)

• Gabapentin has been reported to potentially ameliorate existing bruxism 3
• Clonidine may have some benefit 3

Critical Clinical Pitfalls to Avoid

1. Do not prescribe baclofen off-label for bruxism simply because it's a "muscle relaxant"—the mechanism doesn't match the pathophysiology
2. If a patient is already on baclofen (e.g., for spasticity) and develops bruxism, do NOT abruptly discontinue—taper slowly to avoid life-threatening withdrawal 7
3. Recognize that bruxism has psychological components: Address underlying anxiety, stress, and depression, which are strongly associated with bruxism 8
4. Differentiate awake bruxism from sleep bruxism: Management strategies differ 2, 9

When to Consider Specialist Referral

• Severe bruxism causing functional impairment (difficulty speaking, chewing, swallowing)
• Presence of significant dental damage requiring intervention
• Comorbid psychiatric conditions (depression, anxiety) that may benefit from integrated treatment 8
• Failed conservative management after 3-6 months

The evidence is clear: baclofen has no role in treating jaw clenching and carries unnecessary risks. Start with conservative behavioral approaches, consider occlusal splints for dental protection, and reserve botulinum toxin for severe, refractory cases with functional impairment.